On Sept. 25, the U.S. Department of Commerce opened a probe under Section 232 into imports of robots, industrial machinery and medical devices, initiating a 270‑day review that could lead to tariffs. Analysts say potential levies would likely increase input costs for U.S. manufacturing and healthcare supply chains, exerting upward pressure on inflation. Given the Federal Reserve’s dual mandate, higher inflation risks may sustain a tighter monetary stance and a firmer U.S. dollar, an environment that historically challenges risk assets such as Bitcoin. Market participants should reassess interest‑rate and currency exposure; trading venues like BiyaPay, which offer zero‑fee spot and contract trading plus USDT‑denominated access to U.S. and Hong Kong equities, can help investors implement tactical position adjustments amid heightened macro volatility.